Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

被引：0
|
作者：
Park, Deborah Y. [1 ]
Poudel, Shyam K. [2 ]
Jia, Xuefei [3 ]
Wilks, Mailey Lynn [2 ]
Pinkava, Vicki [2 ]
O'Brien, Meghan [2 ]
Tripp, Barbara [2 ]
Song, Jung-Min [2 ]
McCrae, Keith R. [2 ]
Angelini, Dana E. [2 ]
Khorana, Alok A. [2 ]
机构：
[1] Cleveland Clin, Lerner Coll Med, Cleveland Hts, OH USA
[2] Cleveland Clin Fdn, Dept Hematol & Med Oncol, Taussig Canc Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-111897
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1237
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Direct Oral Anticoagulants for the Treatment of Cancer-Associated Venous Thromboembolism: A Latin American Perspective
    Athanazio, Rodrigo Abensur
    Ceresetto, Jose Manuel
    Marfil Rivera, Luis Javier
    Cesarman-Maus, Gabriela
    Galvez, Kenny
    Marques, Marcos Areas
    Tabares, Aldo Hugo
    Ortiz Santacruz, Carlos Alberto
    Santini, Fernando Costa
    Corrales, Luis
    Cohen, Alexander T.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [22] Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism
    Ullah, Fauzia
    Song, Juhee
    Hernandez, Cristhiam M. Rojas
    Kroll, Michael H.
    Escalante, Carmelita P.
    Toale, Katy M.
    ONCOLOGIST, 2023, : E1005 - E1016
  • [23] Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?
    Pabinger, Ingrid
    Riedl, Julia
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 136 - 143
  • [24] Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins
    Smrke, Alannah
    Gross, Peter L.
    FRONTIERS IN MEDICINE, 2017, 4
  • [25] Direct Oral Anticoagulants Compared to Low Molecular Weight Heparin in the Treatment of Cancer-Associated Thromboembolism: An Updated Meta-Analysis of Randomized Controlled Trails
    Wongsaengsak, Sariya
    Ball, Somedeb
    Khandelwal, Nuvneet
    Tikue, Alay
    Motes, Arunee
    Jahan, Nusrat
    Thein, Kyaw Zin
    Tijani, Lukman
    BLOOD, 2019, 134
  • [26] Drug-Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants
    Hellfritzsch, Maja
    Henriksen, Jakob Norgaard
    Holt, Marianne Ingerslev
    Grove, Erik Lerkevang
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024, 50 (03): : 489 - 498
  • [27] Comparison of Direct Oral Anticoagulants Versus Low-Molecular-Weight-Heparins for the Treatment of Cancer Associated Thrombosis
    Phelps, Megan K.
    Wiczer, Tracy E.
    Erdeljac, H. Paige
    Van Deusen, Kelsey R.
    Porter, Kyle
    Phillips, Gary
    Wang, Tzu-Fei
    BLOOD, 2016, 128 (22)
  • [28] Direct Oral Anticoagulants in the Management of Cancer-Associated Venous Thromboembolism: A Comprehensive Review
    Abdellatif, Mohamed
    ADVANCES IN PHARMACOLOGY AND PHARMACY, 2022, 10 (02) : 138 - 144
  • [29] Current Management of Cancer-associated Venous Thromboembolism: Focus on Direct Oral Anticoagulants
    Kim, Sang-A
    Yhim, Ho-Young
    Bang, Soo-Mee
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (06)
  • [30] Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism
    Zeng, Jie
    Zhang, Xuhui
    Lip, Gregory Y. H.
    Shu, Xiaochen
    Thabane, Lehana
    Tian, Junzhang
    Li, Guowei
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
12345